Phreesia, Inc. (NYSE:PHR) CFO Balaji Gandhi Sells 948 Shares of Stock

Phreesia, Inc. (NYSE:PHR) CFO Balaji Gandhi sold 948 shares of the firm’s stock in a transaction on Monday, April 15th. The shares were sold at an average price of $22.86, for a total transaction of $21,671.28. Following the sale, the chief financial officer now directly owns 97,230 shares of the company’s stock, valued at $2,222,677.80. The transaction was disclosed in a document filed with the SEC, which is available at this link.

Balaji Gandhi also recently made the following trade(s):

• On Monday, April 8th, Balaji Gandhi sold 7,778 shares of Phreesia stock. The shares were sold at an average price of $22.62, for a total transaction of $175,938.36.
• On Monday, March 25th, Balaji Gandhi sold 3,504 shares of Phreesia stock. The shares were sold at an average price of $23.21, for a total transaction of $81,327.84.

Phreesia Stock Up 0.7 %

PHR stock opened at $23.16 on Thursday. The firm’s 50-day simple moving average is $24.49 and its 200 day simple moving average is $21.25. The stock has a market cap of $1.31 billion, a PE ratio of -9.19 and a beta of 0.92. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.02. Phreesia, Inc. has a fifty-two week low of $12.05 and a fifty-two week high of $34.98.

Phreesia (NYSE:PHR) last announced its quarterly earnings data on Thursday, March 14th. The company reported ($0.56) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.58) by $0.02. The company had revenue of $95.00 million for the quarter, compared to analysts’ expectations of $93.52 million. Phreesia had a negative net margin of 38.42% and a negative return on equity of 53.33%. The business’s revenue was up 24.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.72) EPS. As a group, sell-side analysts predict that Phreesia, Inc. will post -1.48 EPS for the current year.

Analyst Ratings Changes

A number of research analysts have commented on PHR shares. Canaccord Genuity Group increased their price objective on shares of Phreesia from $36.00 to $37.00 and gave the company a “buy” rating in a research note on Friday, March 15th. DA Davidson reiterated a “neutral” rating and set a $32.00 price objective on shares of Phreesia in a research note on Friday, March 15th. Truist Financial initiated coverage on shares of Phreesia in a research note on Monday, February 26th. They set a “buy” rating and a $35.00 price objective on the stock. JMP Securities raised their price target on shares of Phreesia from $28.00 to $30.00 and gave the stock a “market outperform” rating in a research report on Thursday, March 21st. Finally, Royal Bank of Canada restated a “sector perform” rating and issued a $23.00 price target on shares of Phreesia in a research report on Thursday, March 21st. Two research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $31.62.

Hedge Funds Weigh In On Phreesia

Hedge funds have recently made changes to their positions in the business. International Assets Investment Management LLC grew its stake in shares of Phreesia by 1,987.3% in the 4th quarter. International Assets Investment Management LLC now owns 1,482 shares of the company’s stock worth $34,000 after purchasing an additional 1,411 shares during the last quarter. Captrust Financial Advisors increased its position in shares of Phreesia by 154.6% in the second quarter. Captrust Financial Advisors now owns 1,426 shares of the company’s stock worth $36,000 after acquiring an additional 866 shares in the last quarter. Acadian Asset Management LLC purchased a new position in shares of Phreesia in the first quarter worth approximately $43,000. State of Wyoming increased its position in shares of Phreesia by 34.6% in the second quarter. State of Wyoming now owns 1,918 shares of the company’s stock worth $59,000 after acquiring an additional 493 shares in the last quarter. Finally, Tower Research Capital LLC TRC increased its position in shares of Phreesia by 85.4% in the third quarter. Tower Research Capital LLC TRC now owns 3,137 shares of the company’s stock worth $80,000 after acquiring an additional 1,445 shares in the last quarter. Institutional investors and hedge funds own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.